01 / Vendor Profile
10X GENOMICS, INC. Federal Contracts and Awards
UEI D1NLDEZ14TV5 · CAGE 7EWK7
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $51.60M in net contract obligations to 10X GENOMICS, INC. across 1,218 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
10X GENOMICS, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$10.74M
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $4.01M | 98 | 5 | — |
| FY 2020 | $6.24M | 151 | 6 | +55.8% |
| FY 2021 | $5.74M | 178 | 7 | −8.0% |
| FY 2022 | $8.46M | 208 | 6 | +47.3% |
| FY 2023 | $8.39M | 207 | 5 | −0.7% |
| FY 2024 | $8.03M | 199 | 6 | −4.3% |
| FY 2025 | $10.74M | 177 | 7 | +33.7% |
04 / Federal Customers
Which federal agencies buy from 10X GENOMICS, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $42.77M | 1,105 | 82.9% | |
| 97DH | $2.94M | 11 | 5.7% | |
| 3600 | $2.92M | 48 | 5.7% | |
| 7523 | $1.30M | 15 | 2.5% | |
| 8000 | $418.1K | 9 | 0.8% | |
| 7524 | $396.9K | 14 | 0.8% | |
| 97HW | $393.7K | 2 | 0.8% | |
| 12H2 | $300.6K | 10 | 0.6% | |
| 2100 | $104.7K | 1 | 0.2% | |
| 6800 | $49.9K | 2 | 0.1% |
05 / Contracting Offices
Which contracting offices buy from 10X GENOMICS, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $12.95M | 343 | 25.1% | |
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $10.49M | 118 | 20.3% | |
| 75N95D | NATIONAL INSTITUTES OF HEALTH | $6.66M | 120 | 12.9% | |
| HT0014 | DEFENSE HEALTH AGENCY (DHA) | $2.94M | 11 | 5.7% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $2.50M | 63 | 4.8% | |
| 75N940 | NATIONAL INSTITUTES OF HEALTH | $1.65M | 67 | 3.2% | |
| 75N980 | NATIONAL INSTITUTES OF HEALTH | $1.46M | 34 | 2.8% | |
| 75N910 | NATIONAL INSTITUTES OF HEALTH | $1.40M | 73 | 2.7% | |
| 75N92B | NATIONAL INSTITUTES OF HEALTH | $1.36M | 72 | 2.6% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $1.30M | 15 | 2.5% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $27.65M | 479 | 9 | 53.6% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $9.55M | 279 | 3 | 18.5% |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | $7.64M | 290 | 3 | 14.8% |
| 621399 | OFFICES OF ALL OTHER MISCELLANEOUS HEALTH PRACTITIONERS | $2.94M | 11 | 1 | 5.7% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $1.35M | 47 | 3 | 2.6% |
| 811210 | ELECTRONIC AND PRECISION EQUIPMENT REPAIR AND MAINTENANCE | $620.7K | 37 | 3 | 1.2% |
| 621511 | MEDICAL LABORATORIES | $268.0K | 2 | 2 | 0.5% |
| 325998 | ALL OTHER MISCELLANEOUS CHEMICAL PRODUCT AND PREPARATION MANUFACTURING | $247.8K | 12 | 1 | 0.5% |
| 339113 | SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING | $138.9K | 8 | 1 | 0.3% |
| 334510 | ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS MANUFACTURING | $136.8K | 3 | 2 | 0.3% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $19.90M | 409 | 8 | 38.6% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $12.49M | 249 | 4 | 24.2% |
| 6505 | DRUGS AND BIOLOGICALS | $7.32M | 243 | 2 | 14.2% |
| 6810 | CHEMICALS | $5.16M | 176 | 2 | 10.0% |
| Q999 | MEDICAL- OTHER | $2.94M | 11 | 1 | 5.7% |
| J066 | MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT | $945.8K | 55 | 5 | 1.8% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $452.6K | 8 | 2 | 0.9% |
| Q301 | MEDICAL- LABORATORY TESTING | $405.2K | 10 | 2 | 0.8% |
| 6509 | DRUGS AND BIOLOGICALS, VETERINARY USE | $394.7K | 13 | 1 | 0.8% |
| 6632 | ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $344.9K | 2 | 1 | 0.7% |
08 / Competition Pattern
How was 10X GENOMICS, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for 10X GENOMICS, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N95D25F40048 | Sep 29, 2025 | $87.7K | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NIA | 334516 | 6550 |
10 / Interpreting the Profile
How should you evaluate 10X GENOMICS, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.